A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD

Clinical trial NCT05414422 · COMPLETED

Trial details

NCT number: NCT05414422
Sponsor: Perception Neuroscience
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment Resistant Depression

Start date: 2022-02-01
Primary completion: 2022-11-10
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.